Thomas Braxton King, President & CEO at Alexza Pharmaceuticals Inc. (ALXA), sold 12,500 shares at $6.20 ($76K) on 2008-05-12, disclosed to the SEC on 2008-05-13.
Scheduled sale ($76k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.99 | 300 | $2K | 2.3% |
| 2 | $6.00 | 1,600 | $10K | 12.6% |
| 3 | $6.01 | 600 | $4K | 4.7% |
| 4 | $6.05 | 2,400 | $15K | 19.0% |
| 5 | $6.11 | 800 | $5K | 6.4% |
| 6 | $6.15 | 2,700 |
| $17K |
| 21.7% |
| 7 | $6.16 | 1,000 | $6K | 8.1% |
| 8 | $6.20 | 500 | $3K | 4.1% |
| 9 | $6.23 | 2,500 | $16K | 20.4% |
| 10 | $6.25 | 100 | $625 | 0.8% |
| Total | $6.12 avg | 12,500 | $76K | 100% |
| Filing → |
| ALXA | SELL | 2012-08-29 | $41K | — | Filing → |
| ALXA | SELL | 2012-06-08 | $22K | — | Filing → |
| ALXA | SELL | 2009-12-21 | $100K | — | Filing → |